Barcode Nano
1 known investors
Barcode Nanotech develops nanoparticle-based delivery vehicles for RNA/DNA therapeutics and vaccines, using proprietary lipids and an in vivo and AI-based screening platform to target specific tissues and cells beyond the liver. Its platform aims at selective indications such as hard-to-treat cancers and metabolic diseases.
AI & Machine LearningBiotechDeep Tech